Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review
- 1 February 2017
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 76 (2) , 368-374
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: Results of two randomized, investigator-blinded, multicenter, international, controlled trials∗Journal of the American Academy of Dermatology, 2008
- A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitisJournal of the American Academy of Dermatology, 2005
- Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafineClinical and Experimental Dermatology, 2004
- A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitisBritish Journal of Dermatology, 2001
- Short duration treatment with terbinafine for tinea capitis caused byTrichophytonorMicrosporumspeciesBritish Journal of Dermatology, 1999
- Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitisJournal of Dermatological Treatment, 1999
- A randomized double-blind comparative study of terbinafine and griseofulvin in tinea capitisJournal of Dermatological Treatment, 1995
- Treating tinea capitis: Should ketoconazole replace griseofulvin?The Journal of Pediatrics, 1988
- Double blind study of ketoconazole and griseofulvin in dermatophytosesThe Pediatric Infectious Disease Journal, 1988
- Comparison of ketoconazole and griseofulvin for treatment of tinea capitis in childhood: A preliminary studyPediatric Emergency Care, 1985